Among the companies with shares expected to actively trade in Thursday's session are Oracle Corp. (ORCL), Rite Aid Corp. (RAD) and Agilent Technologies Inc. (A).

Oracle returned to modest growth in its first quarter as demand for the company's software appeared to rebound a bit despite pressure from online rivals. But the company said revenue rose 2% in the fiscal period ended Aug. 31, less than analysts expected, while profit rose 8%. Shares fell 1.4% to $33.40 in premarket trading.

Rite Aid swung to an unexpected fiscal second-quarter profit due to continued sales growth and stronger margins. Shares jumped 11% to $4.13 in recent premarket trading as the drugstore chain also raised its guidance for the year.

Diversified testing-equipment company Agilent plans to break up into two publicly traded firms, spinning off its electronic-measurement products business, which has faced weak demand lately. The other company will focus on life sciences and diagnostics and retain the Agilent name. Shares jumped 11% premarket to $54.50.

Pier 1 Imports Inc.'s (PIR) fiscal second-quarter earnings fell 32% as the home-furnishings retailer logged weaker margins and said its traffic was lower-than-expected, citing marketing issues. The company lowered its full-year earnings guidance. Shares dropped 10% to $21.21 in light premarket trading.

"Grand Theft Auto V" raked in some $800 million in sales world-wide on its first day, Take-Two Interactive Interactive Software Inc. (TTWO) said. Tuesday's total was the biggest first-day haul for a game in the Rockstar Games series. The prior installment in the 15-year-old franchise pulled in $310 million in its first day, according to Edward Williams at BMO Capital Markets. Shares rose 4.9% to $18.05 premarket.

SS&C Technologies Holdings Inc. (SSNC) said Carlyle Group LP (CG), its third-largest shareholder, will offer all of its 7.47 million shares, or 9.2% stake, in the financial-software company. The company won't receive any of the proceeds from the offering. Shares slipped 3.8% to $37.95 premarket.

Shares of BioMarin Pharmaceutical Inc. (BMRN) jumped 7.6% in premarket trade after Dealreporter said Swiss drug maker Roche Holding AG is lining up debt financing for an acquisition of the maker of drugs to treat rare diseases. A representative from Roche declined to comment on the report, while BioMarin wasn't immediately available for comments. BioMarin surged 9.4% to $84.81 premarket.

Pacific Coast Oil Trust (ROYT) said Pacific Coast Energy Company LP and other selling unitholders intend to offer 13.5 million trust units in an underwritten public offering. The Trust will not sell any trust units in the offering and will not receive any proceeds from the offering. Shares fell 7.1% to $16.70 premarket.

 
   Watch list: 

Apogee Enterprises Inc.'s (APOG) fiscal second-quarter profit jumped 21% as the glass-products designer reported higher architectural glass sales and wider gross margins. But results missed Wall Street's expectations.

Clarcor Inc.'s (CLC) fiscal third-quarter earnings fell 5.2% as the filter-and-packaging company's bottom line was weighed by $7.7 million in pre-tax charges, masking a small net sales increase. Results in the quarter were mixed, as Clarcor's adjusted profit topped expectations but revenue growth fell short.

Sporting-goods retailer Dick's Sporting Goods Inc. (DKS) plans to spend more than $1.8 billion over the next five years on new stores, store upgrades and to expand its e-commerce business in an effort to reach a sales target of $10 billion.

East West Bancorp Inc. (EWBC) agreed to pay roughly $273 million to acquire smaller banking peer MetroCorp Bancshares Inc. (MCBI), a cash-and-stock deal to bolster the larger bank's presence in Houston and enter the Dallas market.

Gentiva Health Services Inc. (GTIV) has agreed to acquire Harden Healthcare Holdings Inc. for $409 million in cash and stock, strengthening the company's core home health and hospice businesses and expanding its service offerings for the dual eligible population. Harden, a provider of home health, hospice and community care services, has a large presence in Texas and several other south central states.

Herman Miller Inc.'s (MLHR) fiscal first-quarter earnings rose 13% as results beat the office-furniture company's expectations behind wider margins and growth in revenue, particularly outside its core North American business.

IHS Inc.'s (IHS) fiscal third-quarter profit shrank 47% as the market-research provider's higher costs outpaced a jump in revenue. Results beat expectations, and the company affirmed its outlook for the year.

McDonald's Corp.'s (MCD) board approved a 5% hike to the fast-food chain's dividend, a move that highlights the company's preference to return cash to shareholders first through dividends, with a secondary focus on buybacks.

In the midst of a merger with Office Depot Inc. (ODP), OfficeMax Inc. (OMX) said Chief Executive Ravi Saligram has withdrawn his name from consideration for chief executive of the combined company. The retailers agreed in February to merge in a deal that valued OfficeMax at around $1.19 billion.

Ralph Lauren Corp. (RL) shuffled some of the premium-brand clothing maker's top executive posts, part of the creation of a so-called "office of the chairman" that comes less than two months after a disappointing quarterly earnings report.

Retrophin Inc. (RTRX) said it has made a proposal to board of Transcept Pharmaceuticals Inc. (TSPT) to acquire all of the shares of Transcept stock that Retrophin doesn't already own for $4 per share in cash.

Scholastic Corp.'s (SCHL) fiscal first-quarter loss narrowed as the children's book publisher offset lower sales of "The Hunger Games" trilogy by trimming costs. It backed its outlook for the year.

Steelcase Inc.'s (SCS) fiscal second-quarter earnings slipped 6.4% as the office-furniture maker recorded an uptick in operating expenses and restructuring costs, while a drop in sales in the company's Europe, Middle East and Africa segment weighed on overall revenue.

Write to Lauren Pollock at lauren.pollock@wsj.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more BioMarin Pharmaceutical Charts.
BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more BioMarin Pharmaceutical Charts.